Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Virology/New Therapies, including Antivirals and Immunotherapy"'
Autor:
Pratikhya Pratikhya, Chun-Ling Jung, Alan J. Waring, Hai Luong, Piotr Ruchala, Martin L. Phillips, Amy L. Cole, Shantanu Sharma, Ewa D. Micewicz, Alexander M. Cole
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e14360 (2010)
PLoS ONE, Vol 5, Iss 12, p e14360 (2010)
Background: Griffithsin, a 121-residue protein isolated from a red algal Griffithsia sp., binds high mannose N-linked glycans of virus surface glycoproteins with extremely high affinity, a property that allows it to prevent the entry of primary isola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1731c3b37448d883ebce544d88ed9672
https://resolver.caltech.edu/CaltechAUTHORS:20110125-105140147
https://resolver.caltech.edu/CaltechAUTHORS:20110125-105140147
Autor:
Regina Weinmüllner, Philipp Graf, Martin Beer, Britta Frank-Gehrke, Christiane Meier, Hermann Unger, Andreas Leibbrandt, Andreas Grassauer, Donata Kalthoff, Marielle König-Schuster, Tamas Fazekas, Eva Prieschl-Grassauer, Bettina Pflugfelder
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e14320 (2010)
PLoS ONE, Vol 5, Iss 12, p e14320 (2010)
The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated
Autor:
Laura I. Levi, Malia J. McPherson, Jamie J. Arnold, Stéphanie Beaucourt, Bruno Baron, Marco Vignuzzi, Nina F. Gnädig
Publikováno v:
PLoS Pathogens
PLoS Pathogens, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Public Library of Science, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Vol 6, Iss 10, p e1001163 (2010)
PLoS Pathogens, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Public Library of Science, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Vol 6, Iss 10, p e1001163 (2010)
In a screen for RNA mutagen resistance, we isolated a high fidelity RNA dependent RNA polymerase (RdRp) variant of Coxsackie virus B3 (CVB3). Curiously, this variant A372V is also resistant to amiloride. We hypothesize that amiloride has a previously
Autor:
Paul T. Wingfield, David A. Davis, Robert Yarchoan, Erin E. Soule, Irene R. Tebbs, Stephen J. Stahl, Sarah I. Daniels
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13595 (2010)
PLoS ONE
PLoS ONE
BackgroundMaturation of human immunodeficiency virus type 1 (HIV-1) occurs upon activation of HIV-1 protease embedded within GagProPol precursors and cleavage of Gag and GagProPol polyproteins. Although reversible oxidation can regulate mature protea
Publikováno v:
PLoS Pathogens, Vol 6, Iss 10, p e1001157 (2010)
PLoS Pathogens
PLoS Pathogens
Flaviviruses bud into the endoplasmic reticulum and are transported through the secretory pathway, where the mildly acidic environment triggers particle rearrangement and allows furin processing of the prM protein to pr and M. The peripheral pr pepti
Autor:
Maki Kiso, Yoshihiro Kawaoka, Yousuke Furuta, Ryo Takano, Makoto Yamashita, Satoshi Kakugawa, Masayuki Shimojima, Kei Takahashi, Kyoko Shinya, Makoto Ozawa, Mai thi Quynh Le, Hiroaki Katsura
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 6, Iss 8, p e1001079 (2010)
PLoS Pathogens, Vol 6, Iss 8, p e1001079 (2010)
Influenza viruses resistant to antiviral drugs emerge frequently. Not surprisingly, the widespread treatment in many countries of patients infected with 2009 pandemic influenza A (H1N1) viruses with the neuraminidase (NA) inhibitors oseltamivir and z
Autor:
Raul Andino, Adam S. Lauring
Publikováno v:
PLoS Pathogens, Vol 6, Iss 7, p e1001005 (2010)
PLoS Pathogens
PLoS Pathogens
A large number of medically important viruses, including HIV, hepatitis C virus, and influenza, have RNA genomes. These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity. This diversity allows a viral popu
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 6, p e1000981 (2010)
PLoS Pathogens, Vol 6, p e1000981 (2010)
Dendritic cells (DCs) contribute to human immunodeficiency virus type 1 (HIV-1) transmission and dissemination by capturing and transporting infectious virus from the mucosa to draining lymph nodes, and transferring these virus particles to CD4+ T ce
Autor:
Wolfgang E. Thasler, Roland M. Schmid, Oliver Ebert, Sabrina Marozin, Alexandra Junger, Nobuyuki Kato, Günter Schneider, Enrico N. De Toni, Jennifer Altomonte, Antonia Rizzani
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 6, p e10988 (2010)
PLoS ONE, Vol 5, Iss 6, p e10988 (2010)
The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is currently being exploited to develop alternative therapeutic strategies for hepatocellular carcinoma (HCC). Identifying key regulators in diverse transduction pathways that de
Autor:
Edward A. Berger, Ira Pastan
Publikováno v:
PLoS Pathogens, Vol 6, Iss 6, p e1000803 (2010)
PLoS Pathogens
PLoS Pathogens
E.A.B. and I.P. are co-inventors on NIH-owned issued patents and patent applications for CD4-PE and 3B3-PE. This work was supported in part by the Intramural Program of the NIH (National Institute of Allergy and Infectious Diseases; National Cancer I